1Ulrike Bernauer,B?rbel Vieth,Rainer Ellrich,Barbara Heinrich-Hirsch,Gerd-Rüdiger J?nig,Ursula Gundert-Remy. CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals[J] 2000,Archives of Toxicology(12):618～624
2Vessela Nedelcheva,Ivan Gut,Pavel Sou?ek,Bronislava Tichavská,Lucie Tynkova,Jaroslav Mráz,F. Peter Guengerich,Magnus Ingelman-Sundberg. Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression[J] 1999,Archives of Toxicology(1):33～40
5Wang RS, Nakajima T, Kawamoto T, et al. Effects of aldehyde dehydrogenase-2 genetic polymorphisms on metabolism of structurally different aldehydes in human liver. Drug Metab Dispos ,2002,30:69-73.
6Nakajima T, Aoyama T. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind Health ,2000,38 : 143-152.
7Benkmann HG, Agarwal DP, Saha N, et al. Monomorphism of formaldehyde dehydrogenase in different populations. Hum Hered, 1991,41:276-278.
8Nakamura K, Iwahashi K, Ameno K, et al. CYP2E1 and clinical features in alcoholics. Neuropsychobiology, 2003, 47: 86-89.
9Teng S, Beard K, Pourahmad J, et al. The formaldehyde metabolic detoxifieation enzyme systems and molecular eytotoxie mechanism in isolated rat hepatoeytes. Chem Biol Interact, 2001, 130-132(1-3) : 285-296.
10Pirmohamed M,Kitteringham NR,Quest LJ,et al. Genetic polymorphism of P450 2El and risk of alcoholic liver disease in Caucasians. Pharmacogenetics, 1995,5 : 351.
